Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05562583
Other study ID # R43AG065080
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2019
Est. completion date April 30, 2022

Study information

Verified date August 2023
Source BrightOutcome
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the proposed study, is to adapt a positive emotion intervention for Alzheimer's Disease (AD) caregivers into a self-guided online format that incorporates social connection components and adaptive system feedback mechanisms to promote intervention adherence. Previous tests of the facilitated version of the program, called SAGE-LEAF (Social Augmentation to self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers), have shown efficacy for improving well-being in dementia caregivers. If effective, the SAGE-LEAF program can be disseminated to Alzheimer's caregivers nationwide through AD treatment and research centers.


Description:

The prevalence of Alzheimer's Disease (AD) and other dementias is steadily climbing and predicted to affect as many as 16 million Americans by 2050. In 2016, 59% of dementia caregivers reported experiencing high levels of emotional and physical stress, and the risk that the chronic stress of dementia caregiving places on caregivers for developing a range of physical and mental health issues is extensively documented. Caregiving-related stress contributes to social isolation, loneliness, and physical illness and increases the risk of caregiver death. Interventions for dementia caregivers have primarily focused on reducing negative emotions and burden. However, over the past few decades, it has become clear that positive emotions are uniquely related to better psychological and physical well-being, independent of the effects of negative emotion suggesting that an intervention that specifically targets positive emotion holds promise for improving caregiver well-being and, ultimately, quality of care for the individual living with AD. The investigators' recent randomized trial of the positive emotion skills intervention, delivered by trained facilitators via the web in N = 170 family caregivers of people with dementia resulted in significant improvements in caregiver psychological well being. However, facilitator-delivered interventions are costly and difficult to implement with fidelity on a large scale. Furthermore, a major challenge to advancing behavioral interventions delivered by trained facilitators is assuring fidelity. The investigators have developed a self-guided online version of the intervention that has shown feasibility and acceptability in several samples, but this version does not capture the critical social connection aspects of the facilitator-delivered intervention. The investigators propose to take the next step toward closing the science-to-practice gap for the positive emotion regulation intervention by tailoring the self-guided online version specifically for dementia caregivers that incorporates the social connection components to combat the loneliness and isolation experienced by many Alzheimer's caregivers. The intervention, called SAGE-LEAF (Social Augmentation of self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers), leverages the lessons learned from the original LEAF project and adapts its positive emotion intervention to AD caregivers in a self-guided format while incorporating social connection components and adaptive system feedback mechanisms to promote intervention adherence.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date April 30, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Adults age 18 and over who identify as the primary caregiver of a family member with Alzheimer's Disease - Co-reside with the family caregiver - Speak and read English - Have internet access and a reliable email address Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SAGE LEAF
SAGE LEAF covers 8 skills and each skill has related home-practice activities that "unlock" every week. Each week will consist of 1-2 days of didactic material and 5-6 days of real-life home practice. Participants can access the skills at their own leisure and as often as they'd like within that week. Participants cannot skip modules with didactic material and can only progress to the next lesson if they have completed the current one. However, participants can return to old lessons or exercises if they choose to do so at a later time.

Locations

Country Name City State
United States Northwestern University Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
BrightOutcome Northwestern University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Kwok I, Lattie EG, Yang D, Summers A, Grote V, Cotten P, Moskowitz JT. Acceptability and Feasibility of a Socially Enhanced, Self-Guided, Positive Emotion Regulation Intervention for Caregivers of Individuals With Dementia: Pilot Intervention Study. JMIR Aging. 2023 Sep 6;6:e46269. doi: 10.2196/46269. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Skill Pages in SAGE-LEAF Accessed by a Participant This is to measure adherence to SAGE-LEAF intervention. Score range: 0-100%. A higher percentage means better adherence to the SAGE-LEAF intervention. Post-study (week 6)
Primary Willingness to Recommend SAGE-LEAF to Other AD Caregivers This is to measure the acceptability of SAGE-LEAF. Score range: 1-10. A higher score indicates higher acceptability. Post-study (week 6)
Primary System Usability Scale This is to measure the usability of SAGE-LEAF. Score range: 0-100. A higher score indicates better usability. Post-study (week 6)
Secondary Zarit Burden Interview Measuring caregiving burden. Score range: 0-88. Higher scores indicate greater burden. Pre-study and post-study (week 6)
Secondary Oberst Caregiving Burden Scale - Time Measuring caregiving burden in terms of time. Score range: 1-5. Higher scores indicate higher levels of caregiver burden. Pre-study and post-study (week 6)
Secondary Oberst Caregiving Burden Scale - Difficulty Measuring caregiving burden in terms of difficulty. Score range: 1-5. Higher scores indicate higher levels of caregiver burden. Pre-study and post-study (week 6)
Secondary Positive Aspects of Caregiving Scale Measuring positive aspects to caregiving for dementia patients. Score range: 5-45. Higher scores indicate better caregivers' outlook on life and self-affirmations. Pre-study and post-study (week 6)
Secondary Role Captivity Sub-scale of Caregiver Reaction Assessment Measuring role captivity in caregiving. Score 1-4. Higher scores indicate stronger feelings of role captivity. Pre-study and post-study (week 6)
Secondary Overload Sub-scale of Caregiver Reaction Assessment Measuring the feeling of overload in caregiving. Score 1-4. Higher scores indicate stronger feelings of overload. Pre-study and post-study (week 6)
Secondary Caregiving Mastery Subscale of the Caregiving Appraisal Measure Measuring caregiving mastery. Score range: 1-5. Higher scores indicate better caregiving mastery. Pre-study and post-study (week 6)
Secondary Cohen's Perceived Stress Scale Measuring perceived stress. Score range: 0-40. Higher scores indicate higher levels of perceived stress Pre-study and post-study (week 6)
Secondary Positive Affect in Differential Emotions Scale Measuring positive emotions. Score range: 1-5. Higher scores indicate higher levels of positive emotions. Pre-study and post-study (week 6)
Secondary Negative Affect in Differential Emotions Scale Measuring positive emotions. Score range: 1-5. Higher scores indicate higher levels of negative emotions. Pre-study and post-study (week 6)
Secondary Patient-Reported Outcomes Measurement Information System - Depression Measuring depression level. Score range: 20-80. Higher scores indicate higher depression levels. Pre-study and post-study (week 6)
Secondary Patient-Reported Outcomes Measurement Information System - Anxiety Measuring anxiety level. Score range: 20-80. Higher scores indicate higher anxiety levels. Pre-study and post-study (week 6)
Secondary Patient-Reported Outcomes Measurement Information System - Sleep Disturbance Measuring sleep disturbance level. Score range: 20-80. Higher scores indicate higher levels of sleep disturbance. Pre-study and post-study (week 6)
Secondary Patient-Reported Outcomes Measurement Information System - Meaning and Purpose Measuring one's sense of life having purpose and that there are good reasons for living. Score range: 20-80. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy. Pre-study and post-study (week 6)
Secondary Patient-Reported Outcomes Measurement Information System - Social Isolation Measuring perceptions of being avoided, excluded, detached, disconnected from, or unknown by, others. Score range: 20-80. Higher scores indicate higher levels of perception of social isolation. Pre-study and post-study (week 6)
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Withdrawn NCT02707978 - F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD) Phase 2